Boehringer Ingelheim, Trayenta (Linagliptin) 5 mg, 30 tabs
Description
Trayenta, also known as linagliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor medication used to treat type 2 diabetes mellitus. It belongs to the class of drugs called incretin mimetics, which work by increasing the levels of incretin hormones in the body.
Incretins are natural substances produced by the intestines that help regulate blood sugar levels by stimulating the release of insulin and slowing down the production of glucose in the liver. By mimicking these incretins, Trayenta helps to lower blood sugar levels without causing a rapid drop (hypoglycemia) or increasing heart rate.
The price includes standard shipping worlwide (192 countries).
The price to be delivered inside Colombia is cheaper (no international shipping fees)
Remember, when ordering some jurisdictions may impose tariffs on imports. It is your responsibility to know your country laws and/or codes. We are not responsible for products seized by customs or any other authority.
** Consult your doctor or a qualified physician before consuming.
Published on: July 30, 2024
Views: 0
About the trader
I am MoneroMAGO now and I firmly stand by the MCEP
I am bullish on Monero and the Circular Economies, I was formerly known as MoneroBULL. I am NOT related to https://twitter.com/monerobull .
My main goal is to help Monero and OUR people to thrive.
Selling and buying product and services for Monero in USA and Colombia (proxies in both countries/markets)
Circular economies and honorable transactions are the way to go!
Se habla español!
SimpleX address:
https://simplex.chat/contact#/?v=2-5&smp=smp%3A%2F%2FSkIkI6EPd2D63F4xFKfHk7I1UGZVNn6k1QWZ5rcyr6w%3D%40smp9.simplex.im%2F45nP0-HUhYmHc9yN70iJoaPDUXyBGfwe%23%2F%3Fv%3D1-2%26dh%3DMCowBQYDK2VuAyEAy8qPPcEEySSviQOvRN_v3eGsUibOORRocBoria_vYnk%253D%26srv%3Djssqzccmrcws6bhmn77vgmhfjmhwlyr3u7puw4erkyoosywgl67slqqd.onion
Just send me a message if you are interested in some of my publications
-----BEGIN PGP PUBLIC KEY BLOCK----- mDMEAAAAABYJKwYBBAHaRw8BAQdAq9c2XJh6Fv4TIdsMsz9NqCmCvkhRyJlUesLN C9MpFSC0GE1vbmVyb0JVTExAeG1yYmF6YWFyLmNvbYiUBBMWCgA8FiEEa6RytAyJ /yoKStt2Tte31eBihuQFAgAAAAACGwMFCwkIBwIDIgIBBhUKCQgLAgQWAgMBAh4H AheAAAoJEE7Xt9XgYobkkS8BAM+dU2Xjx+QgJwjRx/ce98l9aaittQfOfHbnnG0y Qh15AP0SbBgI6JAwkI8JIdtGunI+7JW6164pBlag1spnncGzB7g4BAAAAAASCisG AQQBl1UBBQEBB0CGKLbMn7pdREHRl7aMI410D93OviLmkdnDWd02HE20aAMBCAeI eAQYFgoAIBYhBGukcrQMif8qCkrbdk7Xt9XgYobkBQIAAAAAAhsMAAoJEE7Xt9Xg YobkzvQA/j8XOZ+d+9My5MFkOkPBxD6fN7SkmRJ5D7UC2fWZbf+1AQDwSv1QwdW5 5moYoMCO0cPatfwe7gYTxqpbMq2Kc+mrDw== =ZGAq -----END PGP PUBLIC KEY BLOCK-----